Interstitial Fibrosis and Tubular Atrophy (IFTA), Antibody Mediated Rejection (ABMR) and Recurrent Disease as the Major Causes of Late Renal Allograft Loss.

被引:0
|
作者
Horgan, P. [1 ]
Huhn, L. [1 ]
Atkinson, D. [2 ]
Chand, S. [3 ]
Shabir, S. [3 ]
Krishnan, H. [3 ]
Robinson, K. [3 ]
Williams, A. [3 ]
Ball, S. [3 ]
Neill, D. [3 ]
Skordilis, K. [3 ]
Vydianath, B. [3 ]
Briggs, D. [2 ]
McCloskey, M. [1 ]
Borrows, R. [3 ]
机构
[1] Univ Birmingham, Sch Med, Birmingham, W Midlands, England
[2] NHSBT, Birmingham, W Midlands, England
[3] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A254
引用
收藏
页码:472 / 472
页数:1
相关论文
共 10 条
  • [1] Interstitial Fibrosis and Tubular Atrophy (IFTA), Antibody Mediated Rejection (ABMR) and Recurrent Disease as the Major Causes of Late Renal Allograft Loss.
    Horgan, P.
    Huhn, L.
    Atkinson, D.
    Chand, S.
    Shabir, S.
    Krishnan, H.
    Robinson, K.
    Williams, A.
    Ball, S.
    Neill, D.
    Skordilis, K.
    Vydianath, B.
    Briggs, D.
    McCloskey, M.
    Borrows, R.
    TRANSPLANTATION, 2014, 98 : 472 - 472
  • [2] MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection
    Matz, Mareen
    Heinrich, Frederik
    Lorkowski, Christine
    Wu, Kaiyin
    Klotsche, Jens
    Zhang, Qiang
    Lachmann, Nils
    Durek, Pawel
    Budde, Klemens
    Mashreghi, Mir-Farzin
    PLOS ONE, 2018, 13 (08):
  • [3] Inflammation in Scarred Cortex (i-IFTA) is Significantly Associated with T Cell-mediated Rejection (TCMR), but Not Antibody-mediated Rejection (ABMR), in Renal Allograft Biopsies (Bx)
    Zhang, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 413 - 413
  • [4] Comparative profiles of circulating T-cell subsets and cytokines in Kidney allograft recipients with inflammatory interstitial fibrosis and tubular atrophy and Chronic antibody-mediated rejection
    Yadav, Brijesh
    Prasad, Narayan
    Agarwal, Vikas
    Agrawal, Vinita
    Jain, Manoj
    TRANSPLANTATION, 2024, 108 (09) : 460 - 460
  • [5] Comparative profiles of circulating T-cell subsets and cytokines in Kidney allograft recipients with inflammatory interstitial fibrosis and tubular atrophy and Chronic antibody-mediated rejection
    Yadav, Brijesh
    Prasad, Narayan
    Agarwal, Vikas
    Agrawal, Vinita
    Jain, Manoj
    TRANSPLANTATION, 2024, 108 (9S)
  • [6] A Specific Mechanism for Late Loss of Cardiac Allograft: The Antibody Mediated Rejection (AMR) as a Major Factor of Cardiac Allograft Vasculopathy (CAV)
    Toquet, C.
    Loupy, A.
    Rouvier, P.
    Varnous, S.
    Cazes, A.
    Tible, M.
    Beuscart, T.
    Jouven, X.
    Bruneval, P.
    Van Huyen, J. -P. Duong
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S243 - S243
  • [7] Characterization of a specific mechanism for late loss of cardiac allograft: the antibody mediated rejection (AMR) as a major factor of cardiac allograft vasculopathy (CAV)
    Toquet, C.
    Loupy, A.
    Rouvier, P. H.
    Varnous, S.
    Cazes, A.
    Tible, M.
    Beuscart, T.
    Jouven, X.
    Bruneval, P.
    Van Huyen, J. P. Duong
    EUROPEAN HEART JOURNAL, 2012, 33 : 207 - 207
  • [8] Characterization of a specific mechanism for late loss of cardiac allograft: The antibody mediated rejection (AMR) as a major factor of cardiac allograft vasculopathy (CAV)
    Bruneval, P.
    Toquet, C.
    Loupy, A.
    Pouvier, P.
    Cazes, A.
    van Huyen, J. -P. Duong
    VIRCHOWS ARCHIV, 2012, 461 : S259 - S259
  • [9] Attributing Causes of Kidney Allograft Failure: The Importance of Antibody-Mediated Rejection, Non-Adherence, and Recurrent Disease
    Sellares, J.
    de Freitas, D. G.
    Mengel, M.
    Reeve, J.
    Sis, B.
    Hidalgo, L. G.
    Famulsky, K.
    Halloran, P. F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 399 - 400
  • [10] Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis
    Reischig, Tomas
    Jindra, Pavel
    Hes, Ondrej
    Bouda, Mirko
    Kormunda, Stanislav
    Treska, Vladislav
    TRANSPLANTATION, 2009, 87 (03) : 436 - 444